Alterity Therapeutics Limited logo
Alterity Therapeutics Limited ATHE
$ 2.18 3.81%

Annual report 2022
added 08-31-2022

report update icon

Alterity Therapeutics Limited Financial Statements 2011-2024 | ATHE

Annual Financial Statements Alterity Therapeutics Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- - 895 M 10.8 M 18.8 M 24.5 M 40.9 M 59.8 M 96.7 M 119 M 44 M 45.6 M

Shares

2.41 B 1.7 B 895 M 10.3 M 8.89 M 8.9 M 8.9 M 8.38 M 7.13 M 5.65 M 4.8 M 4.13 M

Historical Prices

0.58 0.85 1.6 0.6 1.61 2.67 2.19 3.6 6.66 67.9 12.7 10.7

Net Income

-12.8 M -15.3 M -13.5 M -12.3 M -8.27 M -7.54 M -7.73 M -5.89 M -13.3 M -7.79 M -5.24 M -6.43 M

Revenue

- - - 109 K 201 K 132 K 143 K 177 K 364 K 151 K 2.53 M 163 K

Cost of Revenue

- - - - - - - - - - - -

Gross Profit

- - - - - - - 177 K 8.21 M 4.49 M 2.53 M 163 K

Operating Income

- - - - - - - - - - - -

Interest Expense

2.28 K 1.3 K 3.88 K - - - - - - - - -

EBITDA

- - - -17.3 M -10.9 M -9.64 M -13.1 M -16.5 M -19.8 M -11.9 M -5.29 M -6.24 M

Operating Expenses

- - - - - - - 16.7 M 28.1 M 16.4 M 7.83 M 6.44 M

General and Administrative Expenses

5.51 M 6.94 M 3.45 M 4.28 M 4.32 M 3.95 M 3.59 M 4.06 M 3.09 M 3.12 M 3.46 M 3.96 M

All numbers in AUD currency

Quarterly Income Statement Alterity Therapeutics Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in AUD currency